# Caroline Gaynor

> Caroline Gaynor is a Series A investor at Lightstone Ventures backing Health Care. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Lightstone Ventures](https://shizune.co/investors/profile/lightstone-ventures)
- Location: Dublin, Ireland
- Total investments: 5
- Last investment: Aug 2025
- Lead investor: 60%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/cgaynor/

Caroline Gaynor is a Series A investor at Lightstone Ventures in Dublin focused on Health Care and Biotechnology. Caroline Gaynor is based out of Dublin, Ireland and is the Chairperson of Irish Venture Capital Association. Caroline Gaynor attended the Trinity College Dublin.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 40% |
| Biotechnology | 2 | 40% |
| Biopharma | 1 | 20% |
| Therapeutics | 1 | 20% |
| Medical Device | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Series B | 1 | 20% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| Ireland | 1 | 20% |
| United States | 1 | 20% |
| United Kingdom | 1 | 20% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| ProVerum Medical | ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $80M | Series B | Aug 25, 2025 |  |
| Amber Therapeutics | Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system. | $101.8M | Series A | Jun 09, 2024 |  |
| ProVerum Medical | ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. |  | Series A | Jan 11, 2022 |  |
| ProVerum Medical | ProVerum Medical is a healthcare company that develops innovative treatments for benign prostatic hyperplasia (BPH). ProVerum develops the ProVee System, which is a minimally invasive implant that gently opens the blocked part of the urethra without cutting, heating, or removing tissue. | $34.1M | Series A | Jan 11, 2022 |  |
| Catamaran Bio | Catamaran Bio is a biotechnology company that specializes in allogeneic immune cell therapies. It offers cell therapy company developing allogeneic, off-the-shelf products for patients with an unmet medical need. It was founded in 2020 and headquartered in Cambridge, Massachusetts. | $42M | Series A | Nov 23, 2020 |  |

5 of 5 investments shown.

## Co-investors
- [Atlantic Bridge University Fund](https://shizune.co/investors/profile/atlantic-bridge-university-fund) — VC Fund, 3 deals together
- [Gilde Healthcare](https://shizune.co/investors/profile/gilde-healthcare-partners) — VC Fund, 3 deals together
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund, 2 deals together
- [OrbiMed](https://shizune.co/investors/profile/orbimed-advisors) — VC Fund, 2 deals together
- [Oxford Science Enterprises](https://shizune.co/investors/profile/oxford-sciences-innovation) — VC Fund, 2 deals together
- [8VC](https://shizune.co/investors/profile/8vc) — VC Fund, 1 deal together

## About Lightstone Ventures

VC Fund · Menlo Park, United States

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.

5 contacts available at Lightstone Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Caroline Gaynor | Principal | https://shizune.co/investors/profile/caroline-gaynor |
| Christina Isacson | Partner | https://shizune.co/investors/profile/christina-isacson |
| Christopher M. Owens | Founder, President & CEO | https://shizune.co/investors/profile/christopher-m-owens |
| Christopher M. Owens | Founder, President & CEO | https://shizune.co/investors/profile/christopher-m-owens-b904 |
| Hank Plain | Partner | https://shizune.co/investors/profile/hank-plain |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Caroline Gaynor invest in?

Caroline Gaynor invests primarily in Health Care, Biotechnology and Biopharma startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in Ireland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Caroline Gaynor last invest?

The most recent investment recorded for Caroline Gaynor closed in Aug 2025. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co